has been added
Aditya
Service Manager
Aditya Aggarwal
Qualified pharmacist and experienced NHS healthcare leader with a blend of experiences across healthcare management, policy & strategy, operations, and innovation, grounded in clinical practice.
I've worked in many areas in the NHS and Government including:
- National policy making in the Prime Minister’s Implementation Unit (PMIU) in the Cabinet Office;
- Innovation adoption and scale in Accelerated Access Collaborative (AAC) in NHS England; and
- Hospital operational (general) management where I currently work.
I have an MSc in Health Policy from Imperial College London, which focused on the implications artificial intelligence (AI) in health and the barriers to scaling innovation, under the supervision of Lord Darzi’s former scientific advisor Professor Hutan Ashrafian.
Pharmacy AI workstream lead at the Institute of Global Health and Innovation (IGHI) AI network at Imperial College London.
I've worked in many areas in the NHS and Government including:
- National policy making in the Prime Minister’s Implementation Unit (PMIU) in the Cabinet Office;
- Innovation adoption and scale in Accelerated Access Collaborative (AAC) in NHS England; and
- Hospital operational (general) management where I currently work.
I have an MSc in Health Policy from Imperial College London, which focused on the implications artificial intelligence (AI) in health and the barriers to scaling innovation, under the supervision of Lord Darzi’s former scientific advisor Professor Hutan Ashrafian.
Pharmacy AI workstream lead at the Institute of Global Health and Innovation (IGHI) AI network at Imperial College London.
Media Coverage
Progressive Britain
Pharmaceutical pollution: How Labour can un-drug our rivers in 3 steps - Progressive BritainHow can Labour end pharmaceutical pollution and the discharge of untreated sewage into our rivers and lakes?
Published:
LabourList
‘NHS waiting times have risen. We need reform, based on what patients want’ - LabourListThe latest NHS stats show an increase in the median wait time from 13.9 weeks in April 2024 ro14.6 weeks in August 2024.
Published:
Financial Times
Letter: Better scrutiny can change the meme craze cultureAn opinion letter written in response to a Chief Investment Officer, who recommended for retail investors to invest in broad-based mutual funds than single stock names.
Published: